Cargando…
Insights into Potential Targets for Therapeutic Intervention in Epilepsy
Epilepsy is a chronic brain disease that affects approximately 65 million people worldwide. However, despite the continuous development of antiepileptic drugs, over 30% patients with epilepsy progress to drug-resistant epilepsy. For this reason, it is a high priority objective in preclinical researc...
Autores principales: | Zavala-Tecuapetla, Cecilia, Cuellar-Herrera, Manola, Luna-Munguia, Hiram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697405/ https://www.ncbi.nlm.nih.gov/pubmed/33202963 http://dx.doi.org/10.3390/ijms21228573 |
Ejemplares similares
-
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
por: Zavala-Tecuapetla, Cecilia, et al.
Publicado: (2022) -
Overview of Nrf2 as Therapeutic Target in Epilepsy
por: Carmona-Aparicio, Liliana, et al.
Publicado: (2015) -
Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022) -
GABAergic Alterations in Neocortex of Patients with Pharmacoresistant Temporal Lobe Epilepsy Can Explain the Comorbidity of Anxiety and Depression: The Potential Impact of Clinical Factors
por: Rocha, Luisa, et al.
Publicado: (2015) -
Epilepsy: Novel therapeutic targets
por: Anovadiya, Ashish P., et al.
Publicado: (2012)